18 ms·
Drug R+D plus approval processes are very expensive both in time (>10 years) and money (>2 American billions) [1] [1] http://csdd.tufts.edu/news/complete_story
by fasteo 11y ago
Drug R+D plus approval processes are very expensive both in time (>10 years) and money (>2 American billions) [1]
[1] http://csdd.tufts.edu/news/complete_story/pr_tufts_csdd_2014_cost_study http://csdd.tufts.edu/news/complete_story/pr_tufts_csdd_2014...
- jvvlimme 11y agoDon't believe everything they say. Tufts is financed by the pharmaceutical industry AND is based on data provided by the industry.
- datashovel 11y agoIn today's world it's hard to believe there are approval processes built to take > 10 years and > $2 billion. I would bet if these processes were carried out "transparently" we would find alot of waste and inefficiencies. I get the feeling things will change once Silicon Valley finally decides to get more invested in the pharmaceutical industry.